This conference seeks to examine the application of the latest technological advancements such as artificial intelligence (AI) and machine learning, virtual and augmented reality, and smart manufacturing, as well as innovations relating to biopharmaceuticals and ATMPs. Attendees will engage in sessions addressing significant industry challenges including PFAS restrictions and drug shortages and access to medicines, as well as explore the keys to efficient project delivery.
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze